Biopharm Co. Stockholders Challenge Director Pay In Del. Suit
Law 360
NOVEMBER 29, 2022
A stockholder of gene therapy company Adverum Biotechnologies Inc. has sued its current and past directors on Adverum's behalf in Delaware's Court of Chancery, seeking to recover allegedly "grossly excessive" compensation that the company had paid to board members.
40 
Let's personalize your content